Human microbiome analysis refers to the process of studying the collection of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit the human body. These microorganisms reside in various body sites such as the gut, skin, mouth, respiratory tract, and reproductive organs, forming complex microbial communities known as the microbiome. The human microbiome plays a crucial role in maintaining health and influencing various physiological processes, including digestion, metabolism, immune function, and protection against pathogens. Imbalances or disruptions in the microbiome composition, known as dysbiosis, have been associated with a wide range of health conditions, including gastrointestinal disorders, metabolic disorders, autoimmune diseases, and mental health disorders.

Human microbiome analysis can provide valuable insights into the composition, diversity, and function of microbial communities within the body. It has applications in research, clinical diagnostics, personalized medicine, and the development of microbiome-targeted therapies and interventions aimed at promoting health and treating diseases. Additionally, microbiome analysis may help identify biomarkers of disease risk, monitor treatment responses, and guide interventions to modulate the microbiome for therapeutic purposes.

The global Human Microbiome Analysis market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Human Microbiome Analysis Industry Forecast” looks at past sales and reviews total world Human Microbiome Analysis sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Microbiome Analysis sales for 2023 through 2029. With Human Microbiome Analysis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Microbiome Analysis industry.

This Insight Report provides a comprehensive analysis of the global Human Microbiome Analysis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Microbiome Analysis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Microbiome Analysis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Microbiome Analysis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Microbiome Analysis.

United States market for Human Microbiome Analysis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Human Microbiome Analysis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Human Microbiome Analysis is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Human Microbiome Analysis players cover:

• Illumina
• IGATech
• Genetic Analysis
• BaseClear
• Microba Life Sciences

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Analysis market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 16S rRNA Sequencing
• Shot Gun Metagenomics
• Metatranscriptomics
• Others

Segmentation by Application:

• Hospitals
• Research Institutes
• Pharmaceutical Companies

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Illumina
• IGATech
• Genetic Analysis
• BaseClear
• Microba Life Sciences
• Viome
• Goodgut
• Origin Sciences
• Ixcela
• ProDigest
• Enterome
• The BioCollective
• ZOE
• Qiagen